The purpose of the present invention is to provide an absorbent sheet capable of sufficiently absorbing exudates exuding from an area of a lesion and exhibiting a powerful deodorizing effect for illness-associated odors. The invention relates to an absorbent sheet with deodorizing functions having an absorbent region and a deodorizing region situated to at least one side of the absorbent region, wherein the absorbent region contains cellulosic fibers, an absorbent polymer and a thermal adhesive resin, and the deodorizing region contains cellulosic fibers, a deodorizing agent and a thermal adhesive resin.

The purpose of the present invention is to provide an absorbent sheet capable of sufficiently absorbing exudates exuding from an area of a lesion and exhibiting a powerful deodorizing effect for illness-associated odors. The invention relates to an absorbent sheet with deodorizing functions having an absorbent region and a deodorizing region situated to at least one side of the absorbent region, wherein the absorbent region contains cellulosic fibers, an absorbent polymer and a thermal adhesive resin, and the deodorizing region contains cellulosic fibers, a deodorizing agent and a thermal adhesive resin.

Provided herein is a antimicrobial sorption composition containing pyrogenic silica and serrathiopeptidase useful for the treatment of wounds such as festering wounds, necrotic wounds, exudative wounds, or wounds with inflammatory infiltration.

Provided herein is a antimicrobial sorption composition containing pyrogenic silica and serrathiopeptidase useful for the treatment of wounds such as festering wounds, necrotic wounds, exudative wounds, or wounds with inflammatory infiltration.

The present invention provides hemostatic compositions comprising components of the flowers of pharmaceutical chamomile (Chamomilla recutita), the leaves of dioecious nettle (Urtica dioica), kaolin, chitosan, fibrinogen and thrombin. Further inclusion of a biocompatible polymeric base, particularly an alignate, generates a composition with superior and broad spectrum hemostatic capabilities, including the ability to arrest arterial hemorrhage. The invention further provides methods of using the inventive compositions in to reduce or stop bleeding, as well as a variety of apparatuses useful in hemostatic contexts that incorporate the inventive compositions. In one particular embodiment, the invention provides hemostatic dressings in which a polymeric layer incorporating chamomile, nettle, kaolin, chitosan, fibrinogen and thrombin components is applied to a textile or fabric material, for example a non-woven viscose.

The present invention provides hemostatic compositions comprising components of the flowers of pharmaceutical chamomile (Chamomilla recutita), the leaves of dioecious nettle (Urtica dioica), kaolin, chitosan, fibrinogen and thrombin. Further inclusion of a biocompatible polymeric base, particularly an alignate, generates a composition with superior and broad spectrum hemostatic capabilities, including the ability to arrest arterial hemorrhage. The invention further provides methods of using the inventive compositions in to reduce or stop bleeding, as well as a variety of apparatuses useful in hemostatic contexts that incorporate the inventive compositions. In one particular embodiment, the invention provides hemostatic dressings in which a polymeric layer incorporating chamomile, nettle, kaolin, chitosan, fibrinogen and thrombin components is applied to a textile or fabric material, for example a non-woven viscose.

A method of forming a hemostatic product. A solution is formed with a polymeric material. An electrospinning system is provided having a first nozzle and a second nozzle. The polymeric material solution is passed through the first nozzle and a hemostatic agent is passed through the second nozzle to form an electrospun fiber in which the polymeric material at least partially covers the hemostatic agent. The electrospun fiber is deposited on a support to form the hemostatic product.

A method of forming a hemostatic product. A solution is formed with a polymeric material. An electrospinning system is provided having a first nozzle and a second nozzle. The polymeric material solution is passed through the first nozzle and a hemostatic agent is passed through the second nozzle to form an electrospun fiber in which the polymeric material at least partially covers the hemostatic agent. The electrospun fiber is deposited on a support to form the hemostatic product.

Provided is a chitosan based hemostatic formulation comprising carboxymethyl chitosan, and methyl cellulose. More particularly, provided is a chitosan based hemostatic formulation comprising carboxymethyl chitosan, methyl cellulose, hydroxy ethyl cellulose, and calcium alginate. Also provided is a chitosan based hemostatic sponge comprising carboxymethyl chitosan, and methyl cellulose. More particularly, provided is a chitosan based hemostatic sponge comprising carboxymethyl chitosan, methyl cellulose, hydroxy ethyl cellulose, and calcium alginate. Further provided is a method of making and using the chitosan based hemostatic sponges.

Provided is a chitosan based hemostatic formulation comprising carboxymethyl chitosan, and methyl cellulose. More particularly, provided is a chitosan based hemostatic formulation comprising carboxymethyl chitosan, methyl cellulose, hydroxy ethyl cellulose, and calcium alginate. Also provided is a chitosan based hemostatic sponge comprising carboxymethyl chitosan, and methyl cellulose. More particularly, provided is a chitosan based hemostatic sponge comprising carboxymethyl chitosan, methyl cellulose, hydroxy ethyl cellulose, and calcium alginate. Further provided is a method of making and using the chitosan based hemostatic sponges.